Key players in Migraine Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 2 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 3 |  Teva Pharmaceutical |
tevapharm.com (opens in a new tab) | 462 reports |
| 4 |  Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,056 reports |
| 5 |  Amgen Inc. |
amgen.com (opens in a new tab) | 693 reports |
| 6 | Lundbeck | — | 132 reports |
Also active in Migraine Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Aurobindo Pharma |
|
| Zydus Lifesciences | |
 Hikma Pharmaceuticals PLC |
|
| TriGemX Bio, Inc. |
|
| Ipsen |
|
| Mylan N.V. | |
 Glenmark Pharmaceuticals |
|
| Salvia BioElectronics |
|
 Dr Reddy’s Laboratories |
|
| Alkem Laboratories Ltd | |
| Brise Pharmaceuticals Co., Ltd. |
|
| Ajanta Pharma Ltd |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Migraine Drugs
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Pfizer Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
- AbbVie Inc. 11 active trials on ClinicalTrials.gov (opens in a new tab)
- TriGemX Bio, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Ipsen 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Lundbeck 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Salvia BioElectronics 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Eli Lilly and Company 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Brise Pharmaceuticals Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Migraine Drugs reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Migraine Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.